Clinical Trial Update: The Efficacy and Safety of Ramosetron in Patients Undergoing Off Pump Coronary Artery Bypass Surgery [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy and safety of Ramosetron in patients undergoing off-pump coronary artery bypass graft surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Ramosetron (ramosetron)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Coronary Artery Bypass Graft Triple Vessel, Hypotension | NA | Status: COMPLETED